Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  13,706 results for ""Angiogenesis Inhibitors""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Angiogenesis inhibitors.
Research Starter

Angiogenesis inhibitors.

  • DEFINITION: Angiogenesis inhibitors prevent the formation of new blood capillaries through a process called angiogenesis, as ... More
  • Salem Health: Cancer (Online Edition), 2025. 3p.
Academic Journal

Recent progress in the exploitation of anti-cancer small molecules targeting angiogenesis.

  • Authors : Zheng Y; College of Traditional Chinese Medicine and Pharmacy, Clinical Medical Research Center, Affiliated Hospital of Jinggangshan University, Jiangxi Province Key Laboratory of Organ Development and Epigenetics, Jinggangshan University, Ji'an, China.; Qiu H

Subjects: Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/pharmacology ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/chemistry ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/chemical synthesis

  • Source: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2025 Dec; Vol. 40 (1), pp. 2584811. Date of Electronic Publication: 2025 Nov 20.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101150203 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Report

Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer

  • Authors : Jundong Wu, Affiliated Cancer Hospital of Shantou University Medical College

  • Source: Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer After Prior CDK4/6

Record details

×
Report

Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients (IMAGINE)

  • Authors : jing xue, Associate chief physician

  • Source: Efficacy and Safety Analysis of Immune Checkpoint Inhibitors Plus Angiogenesis Inhibitors for Treatment of

Record details

×
Academic Journal

U.S. trends of anti-vascular endothelial growth factor use from 2017-2023: An analysis of medicare, medicaid, and commercial insurance.

  • Authors : Malhotra K; Department of Ophthalmology, NYU Grossman School of Medicine, New York, New York, United States of America.; Department of Health Informatics, NYU Langone Health, New York, New York, United States of America.

Subjects: Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/therapeutic use ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage ; Medicare*/Medicare*/Medicare*/statistics & numerical data

  • Source: PloS one [PLoS One] 2026 Jan 13; Vol. 21 (1), pp. e0335390. Date of Electronic Publication: 2026 Jan 13 (Print Publication: 2026).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Evaluation of a New Potential Bevacizumab Biosimilar in Corneal Neovascularization.

Subjects: Bevacizumab*/Bevacizumab*/Bevacizumab*/therapeutic use ; Bevacizumab*/Bevacizumab*/Bevacizumab*/administration & dosage ; Corneal Neovascularization*/Corneal Neovascularization*/Corneal Neovascularization*/drug therapy

  • Source: Turkish journal of ophthalmology [Turk J Ophthalmol] 2025 Dec 25; Vol. 55 (6), pp. 299-304.Publisher: Galenos Yayınevi Country of Publication: Turkey NLM ID: 101686048 Publication Model: Print Cited Medium: Internet ISSN: 2149-8709

Record details

×
Academic Journal

Safety of íntravitreal panitumumab combined with intravitreal ranibizumab in rabbits.

  • Authors : Bikbov MM; Ufa Eye Research Institute of Bashkir State Medical University, Ufa, Russia.; Kazakbaeva GM

Subjects: Ranibizumab*/Ranibizumab*/Ranibizumab*/administration & dosage ; Ranibizumab*/Ranibizumab*/Ranibizumab*/adverse effects ; Ranibizumab*/Ranibizumab*/Ranibizumab*/pharmacology

  • Source: PloS one [PLoS One] 2025 Dec 16; Vol. 20 (12), pp. e0329444. Date of Electronic Publication: 2025 Dec 16 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

The Current Role of Antiangiogenics in Colorectal Cancer.

  • Authors : Basile D; Unit of Medical Oncology, San Giovanni Di Dio Hospital-Crotone, 88900 Crotone, Italy.; Di Nardo P

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/drug therapy ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/blood supply

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Nov 29; Vol. 26 (23). Date of Electronic Publication: 2025 Nov 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Role of Angiogenesis in Retinal Diseases and New Advances in Drug Development.

  • Authors : Boey E; Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, USA.; Zaidi H

Subjects: Drug Development*/Drug Development*/Drug Development*/methods ; Neovascularization, Pathologic*/Neovascularization, Pathologic*/Neovascularization, Pathologic*/drug therapy ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/therapeutic use

  • Source: Cells [Cells] 2025 Nov 24; Vol. 14 (23). Date of Electronic Publication: 2025 Nov 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

Record details

×
  • 1-10 of  13,706 results for ""Angiogenesis Inhibitors""